{
    "nct_id": "NCT03295981",
    "official_title": "Local Bisphosphonate Effect on Recurrence Rate in Extremity Giant Cell Tumor of Bone: a Prospective Randomized Controlled Trial",
    "inclusion_criteria": "* Primary benign GCT of bone\n* Lesion located in an extremity\n* Lesion amenable to reconstruction (intralesional curettage) defined as having at least one intact column of bone after removal\n* No previous systemic bisphosphonate or denosumab therapy\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Recurrent GCT of bone\n* Non-extremity location\n* Lesion too extensive for intralesional treatment, either due to bone loss, joint invasion, or large soft tissue component\n* Children and pregnancy\n* Previous systemic bisphosphonate or denosumab therapy",
    "miscellaneous_criteria": ""
}